ADR
vs
S
S&P/ASX 300
ADR
Over the past 12 months, ADR has underperformed S&P/ASX 300, delivering a return of -58% compared to the S&P/ASX 300's +3% growth.
Stocks Performance
ADR vs S&P/ASX 300
Performance Gap
ADR vs S&P/ASX 300
Performance By Year
ADR vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Adherium Ltd
Glance View
Adherium Ltd. is an international respiratory eHealth company, which is focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. The company offers a range of smart devices for respiratory medications globally. Its Smartinhaler platform supports asthma and chronic obstructive pulmonary disease (COPD) medication adherence solution. The Bluetooth enabled Smartinhaler medication sensors wrap around patients existing inhalers and automatically send usage data to their smartphone. The Smartinhaler application enables patients and healthcare professionals to track medication adherence, set daily reminders, and discover insights into their medication usage. Its application also enables real-time reporting, monitoring, storing and analysis of inhaler use. The SmartinhalerLive platform uses wireless communications technology to provide real time data collection and reporting from the its Smartinhalers.
